欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1349/002
药品名称
Pramipexole Sandoz
活性成分
Pramipexole 0.52 mg
剂型
Prolonged-release tablet
上市许可持有人
Sandoz A/S Denmark
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
France (FR)
Germany (DE)
Pramipexol Ferrrer Healthtech 0,52 mg Retardtabletten
Denmark (DK)
Luxembourg (LU)
Austria (AT)
Pramipexol Ferrer Healthtech 0,52 mg Retardtabletten
许可日期
2014/06/18
最近更新日期
2025/01/28
药物ATC编码
N04BC05 pramipexole
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1349_002_Final PL
Date of last change:2024/09/06
Final Product Information
|
SE_H_1349_002_Final Product Information
Date of last change:2024/09/06
PubAR
|
SE_H_1349_002_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1349_002_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase